Assessment of the association between neuropeptide Y and chronic kidney disease progression
Hend Ahmed Ibrahim Abouelsaad;
Abstract
Context: Neuropeptide Y (NPY) is a sympathetic neurotransmitter with wide-ranging effects in various organ systems, from the central nervous system (CNS) to the cardiovascular (CV) system, the bone and the renal system. There is a strong association between serum concentration of NpY and deterioration of eGFR and proteinuria as suggested by recent studies 1,2, however, its real effect on chronic kidney disease (CKD) progression is uncertain.
Other data
| Title | Assessment of the association between neuropeptide Y and chronic kidney disease progression | Other Titles | دراسة العلاقة بين نيوروببتيد واي و تطور اعتلال الكلى المزمن | Authors | Hend Ahmed Ibrahim Abouelsaad | Issue Date | 2019 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| CC6192.pdf | 376.66 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.